Highres Biosolutions Sustainability Profile
Highres Biosolutions, a leading innovator in the life sciences sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced automation solutions for drug discovery and biological research. Highres Biosolutions offers a unique range of products, including high-throughput screening systems and integrated laboratory automation platforms, designed to enhance efficiency and accuracy in scientific workflows. Their commitment to precision and innovation has garnered recognition within the industry, positioning them as a trusted partner for pharmaceutical and biotechnology companies. With a focus on improving research outcomes, Highres Biosolutions continues to push the boundaries of technology in the life sciences arena.
DitchCarbon Score
How does Highres Biosolutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Highres Biosolutions's score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Highres Biosolutions's reported carbon emissions
HighRes Biosolutions, headquartered in the United States, currently does not report any specific carbon emissions data for the latest year. However, the company is committed to reducing its carbon footprint, as indicated by its near-term targets, which are classified as "Committed" under the Science Based Targets initiative (SBTi). While no absolute emissions figures are available, HighRes Biosolutions is actively engaged in climate commitments within the Pharmaceuticals, Biotechnology, and Life Sciences sector. The company has not set a net-zero target but has established a framework for future emissions reduction initiatives. As of January 2024, HighRes Biosolutions is focused on aligning its operations with industry standards for sustainability, reflecting a growing trend among companies in its sector to address climate change proactively. The absence of specific emissions data highlights the need for ongoing transparency and accountability in corporate climate strategies.
How Carbon Intensive is Highres Biosolutions's Industry?
How Carbon Intensive is Highres Biosolutions's Location?
Highres Biosolutions's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Highres Biosolutions has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
